Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
0.9700
+0.1700 (21.25%)
May 12, 2025, 4:00 PM EDT

Silence Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
194325672547715611
Upgrade
Market Cap Growth
-86.74%-51.64%22.71%-23.44%17.04%-
Upgrade
Enterprise Value
58152600448612549
Upgrade
Last Close Price
0.972.631.503.257.156.97
Upgrade
PS Ratio
7.017.5121.2325.2842.5381.67
Upgrade
PB Ratio
1.722.4230.5420.5861.9349.39
Upgrade
P/TBV Ratio
1.892.6157.6633.06580.25487.96
Upgrade
P/FCF Ratio
----96.09-
Upgrade
P/OCF Ratio
----77.58-
Upgrade
EV/Sales Ratio
2.083.5218.9720.6736.4073.34
Upgrade
EV/FCF Ratio
-0.81---82.24-
Upgrade
Debt / Equity Ratio
0.000.000.020.020.020.04
Upgrade
Debt / FCF Ratio
----0.03-
Upgrade
Asset Turnover
-0.270.250.180.140.08
Upgrade
Quick Ratio
7.9610.364.154.035.412.78
Upgrade
Current Ratio
8.8111.144.624.415.692.99
Upgrade
Return on Equity (ROE)
-106.17%-58.08%-223.22%-273.06%-448.22%-217.21%
Upgrade
Return on Assets (ROA)
--19.24%-26.32%-26.09%-31.44%-29.33%
Upgrade
Return on Capital (ROIC)
-66.81%-39.61%-132.49%-170.42%-317.04%-126.58%
Upgrade
Earnings Yield
-36.85%-13.95%-8.07%-9.20%-7.46%-7.27%
Upgrade
FCF Yield
-36.59%-20.89%-7.37%-10.45%1.04%-2.52%
Upgrade
Buyback Yield / Dilution
-20.41%-24.69%-15.21%-8.58%-8.78%-8.85%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.